Song Da - Thanh Hoa JSC (HNX:THS)
14,900
-1,000 (-6.29%)
At close: Aug 4, 2025
Verve Therapeutics Balance Sheet
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2019 | FY 2018 | FY 2015 | 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '15 Dec 31, 2015 | 2020 |
Cash & Equivalents | 5,635 | 5,065 | 4,362 | 5,059 | 7,872 | 4,263 | Upgrade |
Short-Term Investments | 14,867 | 14,860 | 583.04 | - | - | - | Upgrade |
Cash & Short-Term Investments | 20,502 | 19,925 | 4,945 | 5,059 | 7,872 | 4,263 | Upgrade |
Cash Growth | 256.72% | 302.93% | -2.26% | -35.73% | 84.67% | -23.89% | Upgrade |
Accounts Receivable | 18,787 | 16,979 | 10,599 | 4,943 | 5,150 | 4,744 | Upgrade |
Other Receivables | 4,292 | 2,930 | 3,032 | 4,302 | 5,107 | 5,586 | Upgrade |
Receivables | 23,079 | 19,909 | 13,631 | 9,245 | 10,257 | 10,331 | Upgrade |
Inventory | 64,950 | 42,871 | 32,605 | 26,733 | 36,195 | 19,704 | Upgrade |
Prepaid Expenses | 159.65 | 68.15 | 46.11 | 152.1 | 119.56 | 56.47 | Upgrade |
Other Current Assets | 3,376 | 8,179 | 464.5 | 200.08 | 5,712 | 3,158 | Upgrade |
Total Current Assets | 112,067 | 90,952 | 51,692 | 41,389 | 60,156 | 37,513 | Upgrade |
Property, Plant & Equipment | 14,409 | 16,202 | 11,352 | 13,482 | 11,482 | 37,414 | Upgrade |
Other Long-Term Assets | 20,171 | 12,200 | 12,684 | 13,013 | 13,725 | 144.51 | Upgrade |
Total Assets | 181,747 | 119,354 | 75,728 | 67,885 | 85,363 | 75,072 | Upgrade |
Accounts Payable | 39,437 | 9,407 | 7,405 | 21,567 | 25,937 | 11,874 | Upgrade |
Accrued Expenses | 1,231 | 69.59 | 227.56 | 1,309 | 1,233 | 699.98 | Upgrade |
Short-Term Debt | - | 69,691 | 27,014 | 5,535 | 16,139 | 13,894 | Upgrade |
Current Income Taxes Payable | - | 44.71 | 196.25 | 279.8 | 181.9 | 445.2 | Upgrade |
Current Unearned Revenue | 139.65 | - | - | 27.45 | 20.45 | 1,626 | Upgrade |
Other Current Liabilities | 211.11 | 179.72 | 503.8 | 910.76 | 907.18 | 123.89 | Upgrade |
Total Current Liabilities | 143,511 | 79,407 | 35,347 | 29,630 | 44,419 | 28,664 | Upgrade |
Long-Term Unearned Revenue | - | - | - | - | - | 11,125 | Upgrade |
Other Long-Term Liabilities | 636.68 | 636.68 | - | - | - | - | Upgrade |
Total Liabilities | 144,147 | 80,044 | 35,347 | 29,630 | 44,419 | 39,789 | Upgrade |
Common Stock | 30,000 | 30,000 | 30,000 | 30,000 | 30,000 | 30,000 | Upgrade |
Retained Earnings | 9,761 | 11,472 | 12,543 | 10,417 | 13,106 | 7,445 | Upgrade |
Treasury Stock | -2,162 | -2,162 | -2,162 | -2,162 | -2,162 | -2,162 | Upgrade |
Shareholders' Equity | 37,599 | 39,310 | 40,381 | 38,255 | 40,944 | 35,283 | Upgrade |
Total Liabilities & Equity | 181,747 | 119,354 | 75,728 | 67,885 | 85,363 | 75,072 | Upgrade |
Total Debt | 102,493 | 69,691 | 27,014 | 5,535 | 16,139 | 13,894 | Upgrade |
Net Cash (Debt) | -81,991 | -49,766 | -22,069 | -476.02 | -8,267 | -9,631 | Upgrade |
Net Cash Per Share | -30429.87 | -18431.92 | -8173.70 | -176.32 | -3006.41 | -3567.37 | Upgrade |
Filing Date Shares Outstanding | 2.69 | 2.7 | 2.7 | 2.7 | 2.75 | 2.7 | Upgrade |
Total Common Shares Outstanding | 2.69 | 2.7 | 2.7 | 2.7 | 2.75 | 2.7 | Upgrade |
Working Capital | -31,444 | 11,545 | 16,345 | 11,760 | 15,737 | 8,849 | Upgrade |
Book Value Per Share | 13957.57 | 14559.19 | 14952.60 | 14170.22 | 14889.67 | 13081.65 | Upgrade |
Tangible Book Value | 37,599 | 39,310 | 40,381 | 38,255 | 40,944 | 35,283 | Upgrade |
Tangible Book Value Per Share | 13957.57 | 14559.19 | 14952.60 | 14170.22 | 14889.67 | 13081.65 | Upgrade |
Buildings | - | 16,110 | 16,110 | - | - | - | Upgrade |
Machinery | - | 13,029 | 13,183 | - | - | - | Upgrade |
Construction In Progress | 4,500 | 7,270 | - | - | 98.49 | 3,256 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.